Institutional investors purchased a net $1.5 million shares of ADXS during the quarter ended April 2016. This may signal that the smart money is gaining interest in this company as the 66.67% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PICTET ASSET MANAGEMENT SA Bought 1.3 Million shares of Advaxis Inc
SARISSA CAPITAL MANAGEMENT LP Bought 600.0 Thousand shares of Advaxis Inc
MARSHALL WACE LLP Bought 273.6 Thousand shares of Advaxis Inc